The TTV GUIDE TX project is a Horizon 2020-funded initiative dedicated to enhancing kidney transplant outcomes through personalized immunosuppressive therapies. By utilizing Torque Teno Virus (TTV) levels as biomarkers, we aim to tailor immunosuppression to each patient's unique needs, minimizing risks of rejection and infection. Our consortium comprises leading experts in nephrology, virology, and clinical research, collaborating to revolutionize post-transplant care.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No [896932]. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Spitalgasse 23, Wien,1090,austria
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- https://www.ttv-guide.eu/
- Keywords
- Edmonton.
- HQ
- Wien
Ttv-Guide Questions
Ttv-Guide's website is https://www.ttv-guide.eu/
Ttv-Guide's LinkedIn profile is https://at.linkedin.com/company/ttv-guide-h2020
Ttv-Guide has
2 employees.
View email and phone details for 2
employees at Ttv-Guide.
Ttv-Guide's industry is
Public Health
Ttv-Guide's top competitors are
Qiagen,
Transcriptome Sciences Inc.,
Revista De Robots,
Desy,
Pediatric Interventional Pulmonology,
Genomics England,
Robopac,
Eplan,
Eurofins Transplant Genomics,
Atlas Robots.
Ttv-Guide's categories are Public Health
Ttv-Guide's founding year is 2021
